Avista and Nordic Acquire ConvaTec
March 8th, 2010 by admin
Private equities Avista Capital Partners and Nordic Capital announced their acquisition of ConvaTec, a business unit of Bristol-Myers Squibb Company that is headquartered in Skillman, New Jersey. ConvaTec is a worldwide leader in innovative wound therapeutics marketing and development. It also offers critical care and ostomy care products.
After the acquisition, ConvaTec’s chief executive officer David Johnson admitted that being acquired by Nordic and Avista was good for the company’s road to progress and growth. Both businesses, said Johnson, are continuously working for the growth and development of ConvaTec, which will help them better serve their international consumers and patients.
At the time of the acquisition, Kristoffer Melinder, a partner at Nordic Capital, expressed his observations that ConvaTec and its team have been successful in building their company into one of the best in critical care, therapeutics and ostomy care products. He was one of those who believed that working together with them will make the business even more exciting while also opening up more exceptional opportunities for ConvaTec.
As announced previously, Nordic Capital and Avista Capital Partners integrated Unomedical, a Copenhagen-based leading producer of single-use medical equipment, into ConvaTec. As required by the European Competition Commission, the incorporation did not consider the company’s wound care division, which was later on divested by Nordic Capital.
David Burgstahler, an associate of Avista Capital Partners, also shared his thoughts about the acquisition when he said that with the collaboration of Unomedical and ConvaTec, their newly integrated company will continuously grow.











